StockNews.com Downgrades InfuSystem (NYSEAMERICAN:INFU) to Buy

StockNews.com lowered shares of InfuSystem (NYSEAMERICAN:INFU) from a strong-buy rating to a buy rating in a research note released on Monday morning.

InfuSystem Stock Performance

Shares of NYSEAMERICAN INFU opened at $7.63 on Monday. The company has a quick ratio of 1.54, a current ratio of 1.95 and a debt-to-equity ratio of 0.56. InfuSystem has a twelve month low of $7.57 and a twelve month high of $11.44. The company has a market capitalization of $162.21 million, a P/E ratio of 254.42 and a beta of 1.24.

Institutional Investors Weigh In On InfuSystem

Several institutional investors have recently modified their holdings of the business. Heartland Advisors Inc. lifted its position in InfuSystem by 17.6% during the third quarter. Heartland Advisors Inc. now owns 500,000 shares of the medical instruments supplier’s stock valued at $4,820,000 after purchasing an additional 75,000 shares during the period. Citigroup Inc. lifted its holdings in shares of InfuSystem by 124.1% during the 3rd quarter. Citigroup Inc. now owns 50,640 shares of the medical instruments supplier’s stock valued at $488,000 after buying an additional 28,038 shares during the period. First Eagle Investment Management LLC boosted its stake in shares of InfuSystem by 29.6% in the 3rd quarter. First Eagle Investment Management LLC now owns 468,400 shares of the medical instruments supplier’s stock worth $4,515,000 after buying an additional 107,001 shares during the last quarter. WINTON GROUP Ltd bought a new stake in shares of InfuSystem in the third quarter worth $101,000. Finally, Punch & Associates Investment Management Inc. increased its position in InfuSystem by 3.2% during the third quarter. Punch & Associates Investment Management Inc. now owns 939,918 shares of the medical instruments supplier’s stock valued at $9,061,000 after acquiring an additional 28,807 shares during the last quarter. 71.13% of the stock is owned by hedge funds and other institutional investors.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.